LADUVIGLUSIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H18Cl2N8
Molecular Weight	465.338
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of LADUVIGLUSIB

Structure Search

SMILES

CC1=CNC(=N1)C2=CN=C(NCCNC3=NC=C(C=C3)C#N)N=C2C4=CC=C(Cl)C=C4Cl

InChI

InChIKey=AQGNHMOJWBZFQQ-UHFFFAOYSA-N

InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)

HIDE SMILES / InChI

Molecular Formula	C22H18Cl2N8
Molecular Weight	465.338
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:11:20 UTC 2023` Edited by `admin` on `Sat Dec 16 09:11:20 UTC 2023`
Record UNII	234CMT4GK4
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LADUVIGLUSIB

Official Name

English

CT99021

Code

English

CHIR-99021

Code

English

laduviglusib [INN]

Common Name

English

3-PYRIDINECARBONITRILE, 6-((2-((4-(2,4-DICHLOROPHENYL)-5-(5-METHYL-1H-IMIDAZOL-2-YL)-2-PYRIMIDINYL)AMINO)ETHYL)AMINO)-

Systematic Name

English

CT-99021

Code

English

6-((2-((4-(2,4-DICHLOROPHENYL)-5-(4-METHYL-1H-IMIDAZOL-2-YL)PYRIMIDIN-2-YL)AMINO)ETHYL)AMINO)NICOTINONITRILE

Systematic Name

English

CHR00921

Code

English

LADUVIGLUSIB [USAN]

Common Name

English

FX03

Code

English

CHR-00921

Code

English

CHIR-911

Code

English

Code System Code Type Description

USAN

JK-160

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

INN

11473

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

SMS_ID

300000024958

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

WIKIPEDIA

CHIR99021

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

FDA UNII

234CMT4GK4

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

CHEBI

91091

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

PUBCHEM

9956119

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

NCI_THESAURUS

C177060

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

EPA CompTox

DTXSID90179931

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

CAS

252917-06-9

Created by admin on Sat Dec 16 09:11:20 UTC 2023 , Edited by admin on Sat Dec 16 09:11:20 UTC 2023

PRIMARY

Related Record Type Details


					JJ6Y4XPO7R

GLYCOGEN SYNTHASE KINASE-3 BETA

TARGET -> INHIBITOR

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					5AW8G37ZX5

LADUVIGLUSIB HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					R46MF2V8IP

GLYCOGEN SYNTHASE KINASE-3 ALPHA

TARGET -> INHIBITOR

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					LMF6N91874

LADUVIGLUSIB TRIHYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					X6BE5J2G31

LADUVIGLUSIB DIHYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:

Related Record Type Details


					234CMT4GK4

ACTIVE MOIETY

Amount: